The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome

Journal of Assisted Reproduction and Genetics

Volumn 25, Issue 1, 2008, Pages 29-33

  Pinkas, Haim ^a,b   Sapir, Onit ^a,b   Avrech, Ori M ^a,b   Ben Haroush, Avi ^a,b   Ashkenzi, Jacob ^a,b   Fisch, Benjamin ^a,b   Farhi, Jacob ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

GnRH antagonists; IVF; Oral contraceptive pills

Indexed keywords

CETRORELIX; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; ORAL CONTRACEPTIVE AGENT; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ABORTION; ADULT; ARTICLE; ARTIFICIAL INSEMINATION; CONTROLLED STUDY; ECTOPIC PREGNANCY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVULATION; PREGNANCY RATE; PRIORITY JOURNAL;

ADULT; COHORT STUDIES; CONTRACEPTIVES, ORAL; EMBRYO IMPLANTATION; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY; MALE; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 38649125570     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-007-9189-7     Document Type: Article

References (11)

1. Albano C, Felberbaum RE, Smitz J, Riethuller-Winzen H, Engel J, Diedrich K, et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 2000;15:526-31.
2. Hohmann FP, Macklon NS, Fauser BC. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocinol Metab 2003;88:166-73.
3. Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002;17:874-85.
4. Obruca A, Fischl F, Huber JC. Scheduling OPU in GnRH antagonist cycles. J Reprod Fertil 2000;4:37.
5. Cedrin-Durnerin I, Grange-Dujardin D, Laffy A, Parneix I, Massin N, Galey J, et al. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2004;19:1979-84.
6. Barmat LI, Chantilis SJ, Hurst BS, Dickey RP. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril 2005;83:321-30.
7. Meldrum D, Scott R, Levy MJ, Alper M, Noyes N. A pilot study to assess oral contraceptive (OC) pretreatment in women undergoing controlled ovarian hyperstimulation (COH) in ganirelix acetate cycles. Fertil Steril 2002;78(3 Suppl 1):S176 Abstract P-182.
8. Huirne JA, Van Loenen ACD, Donnez J, Pirard C, Homburg R, Schats R, et al. Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study. Reprod Biomed Online 2006b;13(2):235-45.
9. Rombauts L, Healy D, Norman RJ, on the behalf of the Orgalutran Scheduling Study Group. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum Reprod 2006;21:95-103.
10. Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod 2006;21:352-7.
11. McCullagh P, Nelder JA. Generalised linear models. London: Chapman and Hall; 1989.